Organism 62418 - Tabernaemontana cymosa (APOCYNACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon61043
FamilyAPOCYNACEAE
GenusTABERNAEMONTANA
SpeciesCYMOSA
Species authorityJACQ.
Subspecies
Subspecies authority
Comment
CitationACHENBACH,H: BENIRSCHKE,M: TORRENEGRA,R:. (1997). ALKALOIDS AND OTHER COMPOUNDS FROM SEEDS OF TABERNAEMONTANA CYMOSA.. 45(2)
Geographical areaNORTHERN SOUTH AMERICA
CountryCOLOMBIA

Experiments

Filters
Worktypes (13)
80
63
28
25
6
6
6
6
4
4
4
1
1
No match
Pharmacology (4)
48
16
16
29
No match
Compounds (29)
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
109 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
202858
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
OCTADECA-9-12-DIENOIC ACID
202859
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LUPEOL
202860
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202861
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202862
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202863
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202864
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202865
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
OBTUSIFOLIOL
202866
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
CONDYLOCARPINE
202867
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202868
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202869
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202870
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202871
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202872
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VINCAMINE,16-EPI: 14-15-DEHYDRO:
202873
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
HEYNEANINE
202874
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202875
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202876
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202877
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202878
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202879
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE,10-HYDROXY:
202880
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202881
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202882
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202883
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202884
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202885
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202886
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE,3-OXO:
202887
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202888
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202889
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202890
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202891
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE
202892
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
STEMMADENINE-N-OXIDE
202893
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202894
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202895
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202896
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202897
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202898
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE-N-OXIDE
202899
UV SPECTRUM GIVEN FORQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
ALSTONINE,TETRAHYDRO:
202900
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
VOACRISTINE
202901
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,(+):
202902
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202903
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202904
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202905
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202906
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202907
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):
202908
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Tabernaemontana cymosa (APOCYNACEAE)
ALSTONINE,TETRAHYDRO: 9-(BETA-D-GLUCOPYRANOSYL-OXY):
202909
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202910
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202911
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202912
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202913
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202914
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SITSIRIKINE,ISO:
202915
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (+):
202916
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202917
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202918
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202919
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202920
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202921
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202922
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Tabernaemontana cymosa (APOCYNACEAE)
LYONIRESINOL,2-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):
202923
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,ISO: 3-ALPHA-O-(BETA-D-GLUCOPYRANOSYL)-5'-METHOXY: (-):
202924
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
LARICIRESINOL,ISO: SECO: 8-8-DIMETHOXY-1-O-(BETA-D-GLUCOPYRANOSYL):
202925
QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202926
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202927
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202928
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202929
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202930
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
SWEROSIDE
202931
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202932
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202933
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202934
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202935
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202936
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202937
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):
202938
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202939
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202940
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202941
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202942
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE
202943
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202944
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202945
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202946
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202947
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202948
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
CORONARIDINE
202949
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202950
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202951
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202952
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202953
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202954
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:
202955
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202956
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202957
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202958
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202959
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202960
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
TABERSONINE
202961
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
202962
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
202963
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
202964
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
202965
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
202966
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Tabernaemontana cymosa (APOCYNACEAE)
VOACANGINE,3-OXO:
Show SPARQL Queries (1)